the in vivo experiments also showed that seven out of the nine 14-n-substituted derivatives of carminomycin and rubomycin were practically deprived of antitumor activity ( strain lio-1 ) , while 14-carminomycyl-n-pyridinium bromide and 14-n-succinimidocarminomycin inhibited the tumor growth by 40-60 per cent .
C0007308
carminomycin
C0011015
rubomycin